BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia

"Innovation Down Under: Exploring the Australian BioPharma Industry"

Introduction Nestled on the vast, sunburned continent known for its stunning landscapes and unique wildlife, the Australian BioPharma industry has...

September 05, 2023 | Analysis

Specialised Therapeutics acquires commercialisation rights to new oral MND therapy

ST to partner with Dutch biotech company Treeway BV First CNS therapy in ST therapeutic portfolio The therapy is known as TW001 and is a un...

August 28, 2023 | News

Salvia BioElectronics Treats First Patient with Neuromodulation for Severe Migraine in Australia

The first patient, a 29-year-old woman from Australia who has suffered from debilitating headaches since the age of 14, experienced immediate and...

August 24, 2023 | News

Inmagene Initiates POC Study for Extended Half-Life OX40 mAb in Atopic Dermatitis

IMG-007 is a humanized IgG1 monoclonal antibody (mAb) that specifically binds to the OX40 receptor. Its Fc region has been bioengineered, resulting in...

August 16, 2023 | News

First Patient Dosed in Phase III Prostate Cancer Imaging Study of TLX591-CDx in China

The Phase III Illuccix China study (ClinicalTrials.gov ID: NCT05847348) is a prospective, open-label, single-arm, multicenter study in Chinese...

August 11, 2023 | News

Clarity's theranostic prostate cancer trial advances to highest dose level

Highlights Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) ha...

August 11, 2023 | News

First Patient Dosed in TLX101 Brain Cancer Study for Newly Diagnosed Glioblastoma

IPAX-2 (ClinicalTrials.gov Identifier: NCT05450744) is a Phase I dose escalation study to confirm safety profile of TLX101 in combination with externa...

August 08, 2023 | News

Cicada Innovations Expands to Westmead Health & Innovation District with Investment NSW Support

The incubator will be the first health-focused incubator funded by the NSW government to support pre-revenue health-tech startups in bridging the gap betwe...

August 04, 2023 | News

Peter Mac launches BindiMaps to help patients and visitors with vision impairments

The newly-installed service functions like Google Maps, but has been specifically developed to work indoors with a 10 to 20 times higher accuracy than GPS ...

August 03, 2023 | News

NAVI Raises $2.4 Million for Breakthrough Medical Device Aiding Critically Ill Newborns

After a successful raise Navi Medical Technologies has closed a $2.4 million round of funding, which included a $700,000 lead in...

August 03, 2023 | News

MSD and Moderna Launch Phase 3 Study for Melanoma Treatment

“As we continue our efforts to advance novel treatment options for patients with high-risk Stage IIB-IV melanoma, the initiation of the V940-001 Phas...

July 28, 2023 | News

Hummingbird Bioscience Advances HMBD-001 Phase IB Trials in Australia, Partners with Omico for Faster Clinical Development

Hummingbird Bioscience has initiated two clinical trials in Australia evaluating HMBD-001 in patients with squamous non-small cell lung ca...

July 27, 2023 | News

HaemaLogiX, Peter MacCallum Cancer Centre Announce Myeloma CAR-T Trial Agreement

HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's ...

July 26, 2023 | News

Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial

SABRE (Copper-64 SAR-Bombesin in Biochemical Recurrence of prostate cancer) is a Phase II Positron Emission Tomography (PET) imaging tr...

July 25, 2023 | News

Stay Connected